Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report
  • Print
  • Share
  • E-mail
-

Refusal Details as Recorded in OASIS by FDA

for Refusal UPS-5061224-7/1/1

Manufacturer FEI3006622904
Manufacturer NameCaregen Co.,Ltd.  
Manufacturer Address line 1690-3 Caregen Bldg, Geumjeong-dong  
Manufacturer Address line 2  
Manufacturer's CityGunpo-si  
Manufacturer Province/StateKR-41  
Manufacturer Country/AreaKorea, Republic Of (South)  
Product Code53PD99  
Importer's Product DescriptionSYNTHETIC PROTEIN - RAW COSMETIC INGREDIENT  
Refusal Date09-Mar-2012  
FDA DistrictLOS-DO  
Entry/doc/line/sfx UPS-5061224-7/1/1
FDA Sample AnalysisNo  
FDA Record of Private Lab Sample Analysis No  
Charge(s)
Violation Code Section Charge Statement
FRNMFGREG   502(o), 801(a)(3); MISBRANDING   The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&CA. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act. [Misbranding, Section 502(o), 801(a)(3)].?  
NOT LISTED   502(o), 801(a)(3); MISBRANDING   It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).  
UNAPPROVED   505(a), 801(a)(3); UNAPPROVED NEW DRUG   The article appears to be a new drug without an approved new drug application.  
-
-